tiprankstipranks
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90
1S90
Seres Therapeutics
RESEARCH TOOLSreports
Want to see DE:1S90 full AI Analyst Report?

Seres Therapeutics (1S90) Revenue

1 Followers
StatisticsMarket CapRevenue

Seres Therapeutics Revenue

Seres Therapeutics had a revenue of 358.00K in the quarter ending Mar 31, 2026, with -18.26%. This bring the company's revenue in the last twelve months to 1.15M, Decreased 45.37%. In the fiscal year ending Dec 31, 2025, Seres Therapeutics had annual revenue of 789.00K with Infinity% growth.
Revenue (ttm)
1.15M
Revenue Growth
―
P/S Ratio
79.72
Revenue/Employee
€7,660
Employees
103
Market Cap
€62.90M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
789.00K―+∞%
Dec 31, 2024
―――
Dec 31, 2023
―――
Dec 31, 2022
―-144.93M-100.00%
Dec 31, 2021
144.93M111.71M+336.33%
Dec 31, 2020
33.22M-1.29M-3.74%
Dec 31, 2019
34.51M6.24M+22.07%
Dec 31, 2018
28.27M-3.83M-11.94%
Dec 31, 2017
32.10M――